The first public molecular recognition database, BindingDB supports research, education and practice in drug discovery, pharmacology and related fields.

BindingDB contains 3.1M data for 1.3M Compounds and 9.6K Targets. Of those, 1.5M data for 698K Compounds and 4.7K Targets were curated by BindingDB curators. BindingDB is a FAIRsharing resource.

If BindingDB was of value to your research, please take a moment to donate to this nonprofit project. Your donation will let us provide you with more data and improved service.

Advanced Search

14 articles for thisTarget


The following articles (labelled with PubMed ID or TBD) are for your review

PMID
Data
Article Title
Organization
3D-QSAR and QSSR studies of 3,8-diazabicyclo[4.2.0]octane derivatives as neuronal nicotinic acetylcholine receptors by comparative molecular field analysis (CoMFA).EBI
Burnham Institute For Medical Research
An adamantyl-substituted retinoid-derived molecule that inhibits cancer cell growth and angiogenesis by inducing apoptosis and binds to small heterodimer partner nuclear receptor: effects of modifying its carboxylate group on apoptosis, proliferation, and protein-tyrosine phosphatase activity.EBI
Burnham Institute For Medical Research
Pyrrolotriazine compounds as tam inhibitorsBDB
Incyte
Pyrazole compoundBDB
Sumitomo Dainippon Pharma
Macrocyclic compounds for inhibition of inhibitors of apoptosisBDB
Ensemble Therapeutics
Inhibitors of the renal outer medullary potassium channelBDB
Merck Sharp & Dohme
Substituted pyrido[4,3-d]pyrimidines as Wee-1 inhibitorsBDB
Almac Discovery
Heteroaromatic phenylimidazole derivatives as PDE10A enzyme inhibitorsBDB
H. Lundbeck
The utilization of recombinant prostanoid receptors to determine the affinities and selectivities of prostaglandins and related analogs.BDB
Merck Frosst Centre For Therapeutic Research
The structural basis for the selectivity of benzotriazole inhibitors of PTP1B.BDB
Merck Research Laboratories
Structure-based design of nonpeptide inhibitors of interleukin-1beta converting enzyme (ICE, caspase-1).BDB
Pfizer
Triazolo[1,5-a]pyrimidines as novel CDK2 inhibitors: protein structure-guided design and SAR.BDB
Vernalis (R&D)
Discovery of huperzine A-tacrine hybrids as potent inhibitors of human cholinesterases targeting their midgorge recognition sites.BDB
Universita Di Siena
Thermodynamic and structure guided design of statin based inhibitors of 3-hydroxy-3-methylglutaryl coenzyme A reductase.BDB
Boehringer Ingelheim Pharmaceuticals